Flexion Therapeutics
FLXN
#7310
Rank
$0.45 B
Marketcap
$9.12
Share price
0.00%
Change (1 day)
8,190.91%
Change (1 year)

Revenue for Flexion Therapeutics (FLXN)

Revenue in 2021 (TTM): $0.10 Billion USD

According to Flexion Therapeutics 's latest financial reports the company's current revenue is $0.10 Billion USD. In 2020 the company made a revenue of $85.55 Million USD an increase over the revenue in the year 2019 that were of $72.95 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Flexion Therapeutics from 2018 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)$0.10 B17.36%
2020$85.55 M17.26%
2019$72.95 M223.91%
2018$22.52 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Cara Therapeutics
CARA
$7.13 M-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
$75.36 M-24.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$92.14 B 91,681.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$62.78 B 62,435.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
$0.65 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
$0.71 B 613.94%๐Ÿ‡บ๐Ÿ‡ธ USA